Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026127
Filing Date
2024-11-05
Accepted
2024-11-05 16:15:16
Documents
1
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 form4-11052024_041111.html 4  
1 form4-11052024_041111.xml 4 3375
  Complete submission text file 0001415889-24-026127.txt   4894
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Attar Eyal C. (Reporting) CIK: 0001789076 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 241427655

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)